Woke Medical and RAUMEDIC signed a partnership and distribution agreement at the end of November this year. It pertains to the exclusive distribution of NEUROVENT neurosurgical catheters in the Peoples Republic of China over the next years.

December 16, 2016

Helmbrechts – The Middle Kingdom is one of the strongest growing markets in medical engineering. A significant growth can also be recorded for special products in neurosurgery. Their sales volume has doubled within a few years. Increasing individual traffic and the practice of so-called high-risk sports are, in our modern society, a cause for the increasing number of trauma patients in whom the NEUROVENT catheter is used diagnostically.

“Through the targeted use of RAUMEDIC probes for pressure, temperature and oxygen partial pressure in the brain, severe complications can be averted for the patient. Important functions of the body and sensory performance remain intact”, explains Ingo Bartels, Manager of the Clinics division at RAUMEDIC.

Tiger Zhang, Chief Executive Officer at Woke Medical, and Martin Bayer, Chief Executive Officer at RAUMEDIC AG, met in Helmbrechts in November to sign a long-term contract for a closer collaboration. The name Woke translates to ‘step by step’, according to Tiger Zhang, and this will be brought to life. This marks the beginning of the preparatory work for the approval of RAUMEDIC products in the People’s Republic of China.

“With the concluded contract between Woke Medical and RAUMEDIC, we will participate in one of the fastest growing and largest markets in the world with our NEUROVENT catheters”, says Martin Bayer. “Last spring we opened our new US headquarters in North Carolina, where we realized our concept, ‘local business to local people’. On the basis of this contract, we can now also implement this concept in China.”


RAUMEDIC AG is a development partner and manufacturer of tubing, molded parts, catheters and components for the medical and pharmaceutical industry. The company processes medical-grade thermoplastic polymers and silicones at a total of four production sites in Germany and in the USA. Furthermore, the medical engineering company develops and produces high-precision pressure measurement systems with microchip technology for the indication areas of neuromonitoring and traumatology.

With 60 years of experience in the fields of extrusion, injection molding and assembly, as well as the commitment of currently 700 employees worldwide, RAUMEDIC is optimally equipped to transform the ideas of its customers into well-engineered product solutions. Customer satisfaction and compliance with all relevant statutory and official requirements are the focus of RAUMEDIC’s conception of quality. The basis of this is a quality management system according to ISO 13485 and 108,000 f² (10,000 m²) of clean room production according to ISO 14644 (class 7).

You can find more information at: www.raumedic.com

View website